Gerresheimer AG (ETR:GXI)

Germany flag Germany · Delayed Price · Currency is EUR
80.00
-1.20 (-1.48%)
Feb 21, 2025, 5:37 PM CET
-12.14%
Market Cap 2.76B
Revenue (ttm) 2.01B
Net Income (ttm) 114.30M
Shares Out 34.54M
EPS (ttm) 3.31
PE Ratio 24.18
Forward PE 18.65
Dividend 1.25 (1.54%)
Ex-Dividend Date Jun 6, 2024
Volume 128,430
Average Volume 279,779
Open 80.65
Previous Close 81.20
Day's Range 80.00 - 82.00
52-Week Range 62.90 - 111.20
Beta 0.91
RSI 63.88
Earnings Date Feb 26, 2025

About Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufactu... [Read more]

Sector Healthcare
Founded 1864
Employees 11,660
Stock Exchange Deutsche Börse Xetra
Ticker Symbol GXI
Full Company Profile

Financial Performance

In 2023, Gerresheimer AG's revenue was 1.99 billion, an increase of 9.54% compared to the previous year's 1.82 billion. Earnings were 116.13 million, an increase of 20.81%.

Financial Statements

News

Gerresheimer draws interest from Phillips-Medisize and Bain, Bloomberg News reports

German medical packaging maker Gerresheimer has garnered interest from US medical solutions company Phillips-Medisize and buyout firm Bain Capital for parts or all of Gerresheimer, Bloomberg News repo...

3 days ago - Reuters

EQS-Adhoc: Gerresheimer AG confirms discussions with private equity investors on potential takeover offer

EQS-Ad-hoc: Gerresheimer AG / Key word(s): Tender Offer Gerresheimer AG confirms discussions with private equity investors on potential takeover offer 07-Feb-2025 / 16:26 CET/CEST Disclosure of an ins...

15 days ago - Wallstreet:Online

German packaging firm Gerresheimer exploring sale, Bloomberg News reports

German medical packaging maker Gerresheimer is exploring a potential sale amid interest from private equity funds, Bloomberg News reported on Friday, citing people familiar with the matter.

15 days ago - Reuters

Gerresheimer: FDA grants Tentative Approval of SQ Innovation's Lasix® ONYU* (FOTO)

Düsseldorf (ots) - - Innovative combination product of furosemide and on-body device - Ready-to-market device designed, developed and manufactured by Gerresheimer - Patented device technology for prec...

2 months ago - Wallstreet:Online

EQS-News: Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix ONYU*

EQS-News: Gerresheimer AG / Key word(s): Miscellaneous/Regulatory Admission Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix ONYU* 16.12.2024 / 09:00 CET/CEST The issuer is solely ...

2 months ago - Wallstreet:Online

Gerresheimer Seals Deal: Acquires Bormioli Pharma's Holding Company

Gerresheimer AG has bolstered its market presence by acquiring Blitz LuxCo Sarl, the parent of Bormioli Pharma Group, enhancing its European production and product offerings in the pharma and biotech ...

2 months ago - Wallstreet:Online

EQS-News: Gerresheimer builds new production capacities for glass syringes at Skopje site

EQS-News: Gerresheimer AG / Key word(s): Expansion Gerresheimer builds new production capacities for glass syringes at Skopje site 02.12.2024 / 13:30 CET/CEST The issuer is solely responsible for the ...

2 months ago - Wallstreet:Online

EQS-DD: Gerresheimer AG: Dietmar Siemssen, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 13.11.2024 / 17:56 CET/CEST The issuer is solely responsi...

3 months ago - Wallstreet:Online

EQS-News: Solar power for Gerresheimer site in Momignies, Belgium

EQS-News: Gerresheimer AG / Key word(s): ESG Solar power for Gerresheimer site in Momignies, Belgium 14.10.2024 / 11:00 CET/CEST The issuer is solely responsible for the content of this announcement. ...

4 months ago - Wallstreet:Online

Gerresheimer AG (GRRMY) Q3 2024 Earnings Call Highlights: Navigating Growth Amid Challenges

Gerresheimer AG (GRRMY) Q3 2024 Earnings Call Highlights: Navigating Growth Amid Challenges

4 months ago - GuruFocus

Gerresheimer shares jump as activist investor buys over 5% stake

Gerresheimer's shares rose as much as 6.8% on Wednesday after a regulatory filing showed activist investor Ricky Chad Sandler had bought a 5.43% stake in German medical packaging maker.

4 months ago - Reuters

Gerresheimer AG Slashes Growth Forecast for 2024 and 2025

Gerresheimer AG revises its 2024 and 2025 growth forecasts due to slower market recovery and Hurricane Helene's impact on its US vial plant. Join their conference call on September 30, 2024, for more ...

5 months ago - Wallstreet:Online

EQS-Adhoc: Gerresheimer AG: Adjustment of growth guidance for 2024 and 2025

EQS-Ad-hoc: Gerresheimer AG / Key word(s): Change in Forecast/Development of Sales Gerresheimer AG: Adjustment of growth guidance for 2024 and 2025 30-Sep-2024 / 16:21 CET/CEST Disclosure of an inside...

5 months ago - Wallstreet:Online

Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, together w...

5 months ago - Wallstreet:Online

EQS-News: SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry “Alliance for RTU”

EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Agreement SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry “Alliance for RTU” 26.09.2024 / 12:30 CET/CEST The issuer is...

5 months ago - Wallstreet:Online

EQS-News: Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry “Alliance for RTU”

EQS-News: Gerresheimer AG / Key word(s): Alliance Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry “Alliance for RTU” 26.09.2024 / 12:30 CET/CEST The issuer is solely respon...

5 months ago - Wallstreet:Online

Fill Finish Manufacturing Strategic Business Report 2023-2030 with Focus on 45+ Select Players Including Bausch+Strobel Maschinenfabrik Ilshofen, Becton, Dickinson and Co, & Gerresheimer Among Others – ResearchAndMarkets.com

DUBLIN — The “Fill Finish Manufacturing – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Fill Finish Manufacturing is estimated at ...

6 months ago - Financial Post

Gerresheimer AG (GRRMF) Q2 2024 Earnings Call Transcript

Gerresheimer AG (OTCPK:GRRMF) Q2 2024 Earnings Conference Call July 11, 2024 4:00 AM ET Company Participants Guido Pickert - IR Dietmar Siemssen - CEO Bernd Metzner - CFO Conference Call Participants ...

8 months ago - Seeking Alpha

Gerresheimer core profit meets forecast on weight-loss drug deals pipeline

Germany's Gerresheimer posted second-quarter adjusted core profit in line with market expectations on Thursday, driven by the deal pipeline for its plastics and devices segment, which supplies makers ...

8 months ago - Reuters

Gerresheimer supplies 'key players' in GLP-1 drugs market, CEO says

German packaging and medical equipment maker Gerresheimer is contracted to supply key players in the market for GLP-1 weight loss drugs, its CEO Dietmar Siemssen said on Thursday.

11 months ago - Reuters

Gerresheimer expects sales boost from burgeoning obesity drugs sector

German packaging and medical equipment maker Gerresheimer on Thursday posted adjusted first-quarter core profit in line with expectations of analysts polled by Vara Research, driven by the plastics an...

11 months ago - Reuters

Gerresheimer Makes Solid Start to the Financial Year 2024

Organic growth: Revenues +2.8%, adjusted EBITDA +5.9% Capacity expansion in the Americas, Europe and Asia progresses according to plan Guidance confirmed DUSSELDORF, GERMANY / ACCESSWIRE / April 11, 2...

11 months ago - Accesswire

Gerresheimer CEO dubs weight-loss drugs a meaningful positive catalyst

Dietmar Siemssen – the chief executive of Gerresheimer AG (ETR: GXI) expects strong demand for weight-loss drugs to be a meaningful tailwind for his company. Weight-loss drugs to boost $GXI revenue gr...

11 months ago - Invezz

Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says

Gerresheimer CEO Dietmar Siemssen said he expects about 4% of the company's revenue growth per year from deals to supply makers of drugs for weight loss and diabetes with vials, cartridges, syringes a...

11 months ago - Reuters

Gerresheimer AG (GRRMF) Q4 2023 Earnings Call Transcript

Gerresheimer AG (GRRMF) Q4 2023 Earnings Call Transcript

1 year ago - Seeking Alpha